Goat Anti-Kinesin 1 / UKHC Antibody

$423.00

SKU Unit Size Price

Select a unit size:


SKU: EB05492
Formulation
Supplied at 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin.
Unit Size
100 µg
Storage Instructions
Aliquot and store at -20°C. Minimize freezing and thawing.
Synonym / Alias Names
kinesin heavy chain|U-KHC|KNS1|KINH|KNS|kinesin family member 5B|kinesin 1 (110-120kD)|UKHC|KIF5B
Usage Summary
Additional validation: This antibody has been successfully used in the following paper: Sikorski et al. (2018) PMID: 30377371. Immunofluorescence:This antibody has been successfully used in IF on Human: Connell et al. (2019) PMID: 31587092.
Accession ID
NP_004512.1
Blocking Peptide
EBP05492
Immunogen
Peptide with sequence C-QPVAVRGGGGKQV, from the C Terminus of the protein sequence according to NP_004512.1.
Peptide Sequence
C-QPVAVRGGGGKQV
Purification Method
Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
Shipping Instructions
Refrigerated
Predicted Species
Human, Mouse, Rat, Dog, Cow
Reactive Species
Human
Human Gene ID
3799
Product Grade
ELISA Detection Limit
Antibody detection limit dilution 1:8000.
Western Blot
Approx 110kDa band observed in lysates of the cell lines Jurkat and HeLa (calculated MW of 110kDa according to NP_004512.1). Recommended concentration: 0.5-1.5µg/ml. Primary incubation was 1 hour. This antibody has been successfully used in WB on Human: Connell et al. (2019) PMID: 31587092.
Application Type
Pep-ELISA, WB, IF
Selected References
[{"pmid": 31587092, "intro": "This antibody has been successfully used in WB and IF on Human:", "title": "ESCRT?III?associated proteins and spastin inhibit protrudin?dependent polarised membrane traffic", "author": "James W. Connell, Rachel J. Allison, Catherine E. Rodger, Guy Pearson, Eliska Zlamalova, Evan Reid", "journal": "Cell Mol Life Sci. 2019 Oct 5. doi: 10.1007/s00018-019-03313-z"}, {"pmid": 30246279, "intro": "This antibody has been successfully used in the following paper:", "title": "The large GTPase Mx1 binds Kif5B for cargo transport along microtubules.", "author": "Ringer K, Riehl J, Müller M, Dewes J, Hoff F, Jacob R", "journal": "Traffic. 2018 Dec;19(12):947-964."}, {"pmid": 20094756, "intro": "This antibody (previous batch) has been successfully used in the following paper:", "title": "KIF5C, a kinesin motor involved in apical trafficking of MDCK cells.", "author": "Astanina K, Jacob R.", "journal": "Cell Mol Life Sci. 2010 Apr;67(8):1331-42."}, {"pmid": 18817524, "intro": "This antibody (previous batch) has been successfully used in IF on Human:", "title": "Kinesin-1 (uKHC/KIF5B) is required for bidirectional motility of ER exit sites and efficient ER-to-Golgi\r\ntransport.", "author": "Gupta V, Palmer KJ, Spence P, Hudson A, Stephens DJ.", "journal": "Traffic. 2008 Nov;9(11):1850-66."}, {"pmid": 30377371, "intro": "This antibody has been successfully used in the following paper:", "title": "A high-throughput pipeline for validation of antibodies", "author": "Krzysztof Sikorski, Adi Mehta, Marit Inngjerdingen, Flourina Thakor, Simon Kling, Tomas Kalina, Tuula A. Nyman, Maria Ekman Stensland, Wei Zhou, Gustavo A. De Souza, Lars Holden, Jan Stuchly, Markus Templin and Fridtjof Lund-Johansen", "journal": "Nat Methods. 2018 Nov;15(11):909-912"}, {"pmid": 28490438, "intro": "This antibody (previous batch) has been successfully used in WB on Mouse:", "title": "Deficiency in kinesin-1 recruitment to melanosomes precludes it from facilitating their centrifugal transport.", "author": "Robinson CL, Evans RD, Briggs DA, Ramalho JS, Hume AN.", "journal": "J Cell Sci. 2017 May 10. pii: jcs.186064."}, {"pmid": 26656703, "intro": "This antibody (previous batch) has been successfully used in WB:", "title": "The Basic Domain of Herpes Simplex Virus 1 pUS9 Recruits Kinesin- 1 To Facilitate Egress from Neurons", "author": "Diefenbach RJ, Davis A, Miranda-Saksena M, Fernandez MA, Kelly BJ, Jones CA, LaVail JH, Xue J, Lai J, Cunningham AL", "journal": "J Virol. 2015 Dec 9;90(4):2102-11"}]